FORM 4 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). |
1. Name and Address of Reporting Person*
(Street)
|
2. Issuer Name and Ticker or Trading Symbol
MEDICAL ACTION INDUSTRIES INC [ MDCI ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
||||||||||||||||||||||||
3. Date of Earliest Transaction
(Month/Day/Year) 08/07/2013 | ||||||||||||||||||||||||||
4. If Amendment, Date of Original Filed
(Month/Day/Year) |
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) | 3. Transaction Code (Instr. 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Common Stock, $.001 par value | 10,000 | D | ||||||||
Common Stock $.001 par value | 32,684.101 | I | By 401(k) Plan |
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Employee Stock Options (Right to Buy) | $11.48 | 05/19/2004 | A | 6,000 | (1) | 05/19/2014 | Common Stock | 6,000 | $0 | 6,000 | D | ||||
Employee Stock Options (Right to Buy) | $11.93 | 05/23/2005 | A | 15,000 | (2) | 05/23/2015 | Common Stock | 15,000 | $0 | 15,000 | D | ||||
Employee Stock Options (Right to Buy) | $14.76 | 08/17/2006 | A | 7,500 | (3) | 08/17/2016 | Common Stock | 7,500 | $0 | 7,500 | D | ||||
Employee Stock Options (Right to Buy) | $21.67 | 05/22/2007 | A | 5,000 | (4) | 05/22/2017 | Common Stock | 5,000 | $0 | 5,000 | D | ||||
Employee Stock Options (Right to Buy) | $16.95 | 05/29/2008 | A | 5,000 | (5) | 05/29/2018 | Common Stock | 5,000 | $0 | 5,000 | D | ||||
Employee Stock Options (Right to Buy) | $10.58 | 06/02/2009 | A | 5,000 | (6) | 06/02/2019 | Common Stock | 5,000 | $0 | 5,000 | D | ||||
Employee Stock Options (Right to Buy) | $11.82 | 05/27/2010 | A | 5,000 | (7) | 05/27/2020 | Common Stock | 5,000 | $0 | 5,000 | D | ||||
Employee Stock Options (Right to Buy) | $3.65 | 07/02/2012 | A | 7,500 | (8) | 07/02/2022 | Common Stock | 7,500 | $0 | 7,500 | D | ||||
Employee Stock Options (Right to Buy) | $6.53 | 08/07/2013 | A | 20,000 | (9) | 08/07/2023 | Common Stock | 20,000 | $0 | 20,000 | D |
Explanation of Responses: |
1. The options were granted on 05/19/2004. 3,000 of the options in this grant became exercisable on 05/19/2006 and the remaining 3,000 options became exercisable on 05/19/2007. |
2. The options were granted on 05/23/2005. 7,500 of the options in this grant became exercisable on 05/23/2007 and the remaining 7,500 options became exercisable on 05/23/2008. |
3. The options were granted on 08/17/2006. 3,750 of the options in this grant became exercisable on 08/17/2008 and the remaining 3,750 options became exercisable on 08/17/2009. |
4. The options were granted on 05/22/2007. 2,500 of the options in this grant became exercisable on 05/22/2009 and the remaining 2,500 options became exercisable on 05/22/2010. |
5. The options were granted on 05/29/2008. 2,500 of the options in this grant became exercisable on 05/29/2010 and the remaining 2,500 options became exercisable on 05/29/2011. |
6. The options were granted on 06/02/2009. 1,250 of the options in this grant became exercisable on 06/02/2011, an additional 1,250 options became exercisable on 06/02/2012 and the remaining 2,500 options became exercisable on 06/02/2013. |
7. The options were granted on 05/27/2010. 1,250 options in this grant became exercisable on 05/27/2012 and an additional 1,250 options became exercisable on 05/27/2013. The 2,500 remaining options in this grant will become exercisable on 05/27/2014. |
8. The options were granted on 07/02/2012. 1,875 of the options in this grant will become exercisable on 07/02/2014, an additional 1,875 options will become exercisable on 07/02/2015 and the remaining 3,750 options will become exercisable on 07/02/2016. |
9. The options were granted on 08/07/2013. 5,000 of the options in this grant will become exercisable on 08/07/2015, an additional 5,000 options will become exercisable on 08/07/2016, and the remaining 10,000 options will become exercisable on 08/07/2017. |
/s/ Brian Baker | 08/09/2013 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |